Compound Summary
Dopamine hydrochloride
Compound Information
Dopamine hydrochloride
Compound Name: | Dopamine hydrochloride |
Compound CID: | 65340 |
Synonyms: | Dopamine hydrochloride 62-31-7 3-Hydroxytyramine hydrochloride Dopamine HCl 4-(2-aminoethyl)benzene-1,2-diol hydrochloride More... |
Iupac Name: | 4-(2-aminoethyl)benzene-1,2-diol;hydrochloride |
InChI: | InChI=1S/C8H11NO2.ClH/c9-4-3-6-1-2-7(10)8(11)5-6;/h1-2,5,10-11H,3-4,9H2;1H |
InChIKey: | CTENFNNZBMHDDG-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC(=C(C=C1CCN)O)O.Cl |
Isomeric Smiles: | C1=CC(=C(C=C1CCN)O)O.Cl |
Molecular Weight: | 189.64 |
Molecular Formula: | C8H12ClNO2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Dopamine hydrochloride
Molecular Weight: | 189.64 |
Molecular Formula: | C8H12ClNO2 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 12 |
Complexity: | 119 |
Synonyms
Dopamine hydrochloride
| Dopamine hydrochloride | Dopamine hydrochloride |
|---|---|
Dopamine hydrochloride |
62-31-7 |
3-Hydroxytyramine hydrochloride |
Dopamine HCl |
4-(2-aminoethyl)benzene-1,2-diol hydrochloride |
intropin |
Dopastat |
Revivan |
3,4-Dihydroxyphenethylamine hydrochloride |
Dynatra |
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride |
Dopamine.HCl |
(Dopamine HCl) |
2-(3,4-Dihydroxyphenyl)ethylamine hydrochloride |
4-(2-Aminoethyl)pyrocatechol hydrochloride |
m-Hydroxytyramine hydrochloride |
Dopamine (hydrochloride) |
UNII-7L3E358N9L |
3-Hydroxytyramine, Hydrochloride |
ASL-279 |
P 498 |
4-(2-aminoethyl)benzene-1,2-diol;hydrochloride |
MLS000069419 |
7L3E358N9L |
NSC-169105 |
Cardiosteril |
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride (1:1) |
SMR000059081 |
Dopamine chloride |
Dopamine Fresenius |
62-31-7 (HCl); 51-61-6 (free base) |
3-hydroxytyraminium chloride |
Abbodop |
Inotropin |
Rascordin |
Tensamin |
4-(2-Aminoethyl)-1,2-benzenediol hydrochloride |
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride |
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride (1:1), homopolymer |
1200398-97-5 |
NSC169105 |
EINECS 200-527-8 |
NSC 169105 |
4-(2-aminoethyl)benzene-1,2-diol, chloride |
SR-01000075366 |
.beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride |
3,4-Dihydroxyphenethylamine, HCl |
Actopamin (TN) |
Dopamine HCl salt |
Intropin (TN) |
beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride |
4-(2-Aminoethyl)-1-2-benzenediol |
MFCD00012898 |
Dopamine hydrochloride in dextrose 5% |
Dopamine hydrochloride and dextrose 5% |
3-Hydroxytyramine HCl |
Dopamine hydrochloride USAN:USP:JAN |
3-Hydroxytyramine, HCl |
Opera_ID_218 |
dopamine hydrogen chloride |
DSSTox_CID_550 |
ACMC-1B1TV |
Intropin as hydrochloride |
Dopamini hydrochloridum,(S) |
CHEMBL1557 |
DSSTox_RID_75655 |
DSSTox_GSID_20550 |
SCHEMBL40951 |
MLS001074180 |
SPECTRUM1500263 |
ASL279 |
CHEBI:4698 |
SGCUT00110 |
DTXSID7020550 |
HY-B0451A |
Dopamine hydrochloride and dextrose 5% in plastic container |
Dopamine hydrochloride in dextrose 5% in plastic container |
Dopamine hydrochloride (Inotropin) |
HMS1920I18 |
KUC104380C |
Pharmakon1600-01500263 |
BCP06611 |
to_000060 |
Dopamine hydrochloride (JP17/USP) |
Tox21_201018 |
Tox21_500586 |
CCG-40211 |
NSC756749 |
s2529 |
SBB003668 |
AKOS008056421 |
1, 4-(2-aminoethyl)-, hydrochloride |
KS-5304 |
KSC-10-159 |
LP00586 |
MCULE-8844188424 |
NC00545 |
NSC-756749 |
3,4-dihydoxyphenethylamine hydrochloride |
CAS-62-31-7 |
NCGC00093965-01 |
NCGC00093965-02 |
NCGC00093965-03 |
NCGC00093965-04 |
NCGC00258571-01 |
NCGC00261271-01 |
3,4-dihydroxyphenylethylaminehydrochloride |
AC-12190 |
BD166234 |
H976 |
AB0013398 |
DB-023081 |
3,4-dihydroxyphenyl-ethylamine hydrochloride |
A0305 |
AM20080715 |
EU-0100586 |
FT-0603260 |
FT-0667775 |
FT-0695562 |
SW199608-2 |
W0031 |
D00633 |
F10519 |
H 8502 |
J10150 |
2-(3,4-dihydroxyphenyl)ethyl-1-13c-amine hcl |
4-(2-aminoethyl)benzene-1,2-diol,hydrochloride |
2-(3,4-dihydroxyphenyl)-ethylamine hydrochloride |
A937196 |
Dopamine hydrochloride, puriss., >=98.5% (AT) |
SR-01000075366-1 |
SR-01000075366-8 |
Q27268491 |
F0001-1648 |
Z262221794 |
963AD780-3E96-47B5-9044-7E59F6C84D67 |
Dopamine hydrochloride, certified reference material, TraceCERT(R) |
Dopamine hydrochloride, British Pharmacopoeia (BP) Reference Standard |
Dopamine hydrochloride, European Pharmacopoeia (EP) Reference Standard |
Dopamine hydrochloride, United States Pharmacopeia (USP) Reference Standard |
Dopamine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material |
335081-04-4 |
Dopamine hydrochloride solution, 1.0 mg/mL in methanol with 5% 1 M HCl (as free base), ampule of 1 mL, certified reference material |
Experimental Data
Dopamine hydrochloride
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 5.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Dopamine hydrochloride
Statistics Data
Dopamine hydrochloride
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 5.000000000000000 | 1 | 1 |
Statistics Data Visualization
Dopamine hydrochloride
